The document discusses Ebola virus disease (EVD), including that it is a deadly virus transmitted through contact with infected body fluids that causes hemorrhagic fever. It outlines the virus's history, symptoms, transmission, treatments being tested including vaccines, and current outbreak statistics showing exponential growth in West Africa.
This is a PowerPoint on the Marburg virus, which is a disease similar to Ebola. I very briefly talk about what the disease is, some of the key facts about the structure and death rate, some outbreak history, prevention and treatment and the social-economical impacts that have been caused.
This is a PowerPoint on the Marburg virus, which is a disease similar to Ebola. I very briefly talk about what the disease is, some of the key facts about the structure and death rate, some outbreak history, prevention and treatment and the social-economical impacts that have been caused.
Monkeypox is a zoonotic disease endemic in the Democratic Republic of Congo (DRC) but prevalent also in other countries of Central and Western Africa. The clinical presentation of monkeypox closely resembles the one of smallpox. The mortality rate is officially about 11% however rates as high as 17% have been observed. The disease has been considered rare and not much attention is paid to it. Nonetheless, the incidence of monkeypox increased 20-fold from 1981-1986 to 2005-2007 (two active surveillance programs). More research, surveillance and effective interventions are needed to ensure it would not gain the potential to become the next global pandemic.
Here is a comprehensive and updated presentation on the Monkeypox by noted infectious diseases expert Dr ISHWAR GILADA, Consultant in HIV/STDs, Unison Medicare & Research Centre, and Secretary General, Organised Medicine Academic Guild-OMAG;
President, AIDS Society of India (ASI) &
Governing Council Member, International AIDS Society (IAS)
E-mail: gilada@usa.net, drisgilada@gmail.com
The Ebola virus causes an acute, serious illness which is often fatal if untreated. Ebola virus disease (EVD) first appeared in 1976 in 2 simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic Republic of Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name.
The current outbreak in west Africa, (first cases notified in March 2014), is the largest and most complex Ebola outbreak since the Ebola virus was first discovered in 1976. There have been more cases and deaths in this outbreak than all others combined. It has also spread between countries starting in Guinea then spreading across land borders to Sierra Leone and Liberia, by air (1 traveller only) to Nigeria, and by land (1 traveller) to Senegal.
The most severely affected countries, Guinea, Sierra Leone and Liberia have very weak health systems, lacking human and infrastructural resources, having only recently emerged from long periods of conflict and instability. On August 8, the WHO Director-General declared this outbreak a Public Health Emergency of International Concern.
A separate, unrelated Ebola outbreak began in Boende, Equateur, an isolated part of the Democratic Republic of Congo.
The virus family Filoviridae includes 3 genera: Cuevavirus, Marburgvirus, and Ebolavirus. There are 5 species that have been identified: Zaire, Bundibugyo, Sudan, Reston and Taï Forest. The first 3, Bundibugyo ebolavirus, Zaire ebolavirus, and Sudan ebolavirus have been associated with large outbreaks in Africa. The virus causing the 2014 west African outbreak belongs to the Zaire species.
Ebola virus (Ebola Hemorrhagic Fever) by S Shivani Shastrulagari shivani shastrulagari
WHAT IS EBOLA?
Ebola is the most lethal virus known to man.
Ebola hemorrhagic fever is a very contagious illness that is often fatal in humans and nonhuman primates (monkeys, gorillas, and chimpanzees).
Ebola virus disease (EVD; also Ebola hemorrhagic fever, or EHF), or simply Ebola, is a disease of humans and other primates caused by ebolaviruses. Ebola virus disease is a serious illness that originated in Africa, where there is currently an outbreak
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
Monkeypox is a zoonotic disease endemic in the Democratic Republic of Congo (DRC) but prevalent also in other countries of Central and Western Africa. The clinical presentation of monkeypox closely resembles the one of smallpox. The mortality rate is officially about 11% however rates as high as 17% have been observed. The disease has been considered rare and not much attention is paid to it. Nonetheless, the incidence of monkeypox increased 20-fold from 1981-1986 to 2005-2007 (two active surveillance programs). More research, surveillance and effective interventions are needed to ensure it would not gain the potential to become the next global pandemic.
Here is a comprehensive and updated presentation on the Monkeypox by noted infectious diseases expert Dr ISHWAR GILADA, Consultant in HIV/STDs, Unison Medicare & Research Centre, and Secretary General, Organised Medicine Academic Guild-OMAG;
President, AIDS Society of India (ASI) &
Governing Council Member, International AIDS Society (IAS)
E-mail: gilada@usa.net, drisgilada@gmail.com
The Ebola virus causes an acute, serious illness which is often fatal if untreated. Ebola virus disease (EVD) first appeared in 1976 in 2 simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic Republic of Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name.
The current outbreak in west Africa, (first cases notified in March 2014), is the largest and most complex Ebola outbreak since the Ebola virus was first discovered in 1976. There have been more cases and deaths in this outbreak than all others combined. It has also spread between countries starting in Guinea then spreading across land borders to Sierra Leone and Liberia, by air (1 traveller only) to Nigeria, and by land (1 traveller) to Senegal.
The most severely affected countries, Guinea, Sierra Leone and Liberia have very weak health systems, lacking human and infrastructural resources, having only recently emerged from long periods of conflict and instability. On August 8, the WHO Director-General declared this outbreak a Public Health Emergency of International Concern.
A separate, unrelated Ebola outbreak began in Boende, Equateur, an isolated part of the Democratic Republic of Congo.
The virus family Filoviridae includes 3 genera: Cuevavirus, Marburgvirus, and Ebolavirus. There are 5 species that have been identified: Zaire, Bundibugyo, Sudan, Reston and Taï Forest. The first 3, Bundibugyo ebolavirus, Zaire ebolavirus, and Sudan ebolavirus have been associated with large outbreaks in Africa. The virus causing the 2014 west African outbreak belongs to the Zaire species.
Ebola virus (Ebola Hemorrhagic Fever) by S Shivani Shastrulagari shivani shastrulagari
WHAT IS EBOLA?
Ebola is the most lethal virus known to man.
Ebola hemorrhagic fever is a very contagious illness that is often fatal in humans and nonhuman primates (monkeys, gorillas, and chimpanzees).
Ebola virus disease (EVD; also Ebola hemorrhagic fever, or EHF), or simply Ebola, is a disease of humans and other primates caused by ebolaviruses. Ebola virus disease is a serious illness that originated in Africa, where there is currently an outbreak
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
In light of the of the Ebola outbreak in West Africa the Yale-Tulane ESF-8 Planning and Response Program has produced this special report.
Since most of our student are not back yet from summer break I reached out to past alumni and members of Team Rubicon to assist in putting this report together.
The report was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
Any students, past alumni, or volunteers who would like to work on future slides let me know. Assistance is always welcome.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
1. Ebola virus disease (EVD)
PROF.DR.NAZ.M.ATABAY
DEPARTMENT OF CHEMISTRY
FATIH UNIVERSITY
M.Sc. student : Nabeel.B.Azeez
2. OUTLINES
• WHAT IS EBOLA ?
• HISTORY
• TRANSMISSION
• SYMPTOMS
• VIROLOGICAL AND CLINICAL ASPECTS
• TREATMENTS AND VACCINES
• FACTS ABOUT DISEASE
• REFRENCES
3. What is EBOLA
Ebola virus disease (formerly known
as Ebola hemorrhagic fever, is a type
of virus that passes from wild animals
to humans during contact, including
hunting,handling, cooking and eating
undercooked meat. The Ebola virus
kills up to nine out of ten of the
people who get infected, and as of yet
there is no cure. Medical care can only
help alleviate the suffering.Although
Ebola is quite deadly .
4. What is EBOLA
1- The virus was detected in carcasses of
gorillas, chimpanzees, and duikers, although
their high mortality rate makes them unlikely
to be natural reservoirs 2- The Best candidate to be another reservoir
Which do not show any symptoms is :_
FRUIT BATS
5. HISTORY
• Ebola first appeared in
1976 in two simultaneous
outbreaks :_
1- near Ebola river in the
democratic republic of
Congo .
2- A remote area of Sudan
• In 1989 the disease was
discovered in reston in
group of monkeys which
imported from Philippines
6. TRANSMISSION
• Direct contact (through broken skin
or mucous membranes) with
• a sick person's blood or body fluids
(urine, saliva, faeces, vomit, semen)
• objects (such as needles) that have
been contaminated with infected
body fluids
• infected animals
• High risk groups – bush meat
hunters, forest dwellers, health
workers, relatives of patients,
funeral attendees, corpse handlers,
lab personnel
7.
8. SYMPTOMS
EXPOSURE & INCUBATION
Symptoms typically begin 4-9 days
after exposure ,Though incubation
may last for up to 21 days
COURSE OF ILLNESS
Usually lasts between 6-10 days
•Days 1-3 in the first few days of illness
patients have flu , like symptoms and
profound weakness .
• Days 4-7 around this period patients may
also have vomiting ,nausea , diarrhea , low
blood pressure , headache and anemia .
•Days 7-10 toward the end of illness , there is
confusion and bleeding both internal and
visible all of this progress toward coma ,
shock and finally
Death
9.
10. VIROLOGICAL AND CLINICAL ASPECTS
Genome has 7 genes:
NP, VP35, VP40, GP, VP30, VP24, and L
Structure of Ebola genome and proteins
• Transcribed into 8 sub-genomic mRNA
proteins: 7 structural and 1 nonstructural
• 7 structural proteins:
• nucleoprotein (NP)
• 4 viral/virion proteins (VP35, VP40, VP30, VP24)
• glycoprotein (GP)
• RNA-dependent RNA polymerase (L protein)
• NP, VP35, VP30, L protein: required for
transcription & replication
• VP40, GP, VP24: associated with the
membrane
11. VIRUS STRAINS
5 different strains
• E. Sudan
• E. Zaire
• E. Ivory Coast
• Only one confirmed case
• E. Reston
• Non pathogenic to humans
• E. Bundibugyo
12. TREATMENT AND VACCINES
• Supportive care – rehydration with oral or intravenous fluids and treatment of
Specific symptoms improves survival . There is as yet no proven treatment
available for EVD . However a range of potential treatment including blood
product , immune therapies and drug therapies are currently evaluated . No
licensed vaccines are available yet . But two potential vaccines are under going
human safety testing .
• Convalescent Serum/Plasma transfusion
• Experimental Drugs via Compassionate Use
• Polymerase inhibitor
• Monoclonal antibodies
13. FACTS ABOUT EBOLA
• Ebola is an new and emerging infection
• Ability to cause large outbreaks with high casualty
• Lack of effective treatment and vaccine
• Delayed international response and funding problems
• West Africa could face up to 10,000 new Ebola cases a week within two month ,
WHO warned Tuesday 14th of October 2014 . Adding that the death of rate in the
current outbreak has risen 70% .
• Dr Bruce AlwaradWHO assistance director general said “now the 70 percent
death rate was a high mortality disease and if the world’s response to the ebola
crisis isn't stepped out a lot more people will die and there will be a huge need
to deal with the spiralling number of cases
15. Total: 9216cases:4555 deaths
-------------------
Liberia: 3834cases;2069deaths
Sierra Leone: 2437 cases; 623
deaths
Guinea: 1199cases;735 deaths
Nigeria: 20 cases; 8 deaths
Senegal: 1 case
-------------------
United States: 3 case
In the last 4 weeks, there has been exponential growth of cases in this
devastating outbreak that has created urgency for immediate action.